Leuprolide is a GnRH agonist approved by the FDA for the treatment of endometriosis, uterine leiomyomata (also known as uterine fibroids), central precocious puberty in children, and advanced prostate cancer. The gene discussed is GNRH1; the disease is prostate carcinoma.